Akums Drugs & Pharmaceuticals Ltd (AKUMS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039335, "name": "Akums Drugs", "stock_name": "Akums Drugs", "full_name": "Akums Drugs & Pharmaceuticals Ltd", "name_url": "stocks-analysis/akums-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "620.50", "chg": 2.95, "chgp": "0.48%", "dir": 1, "prev_price": "617.55", "mcapval": "9,766.30 Cr", "mcap": "Small Cap", "scripcode": "544222", "symbol": "AKUMS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE09XN01023", "curr_date": "Jun 23, 03:05 PM", "curr_time": "15:06 PM", "last_traded_at": "Jun 23, 03:05 PM IST", "bse_nse_vol": "2.69 lacs", "exc_status": "Active", "traded_date": "Jun 23, 2026", "traded_date_str": "2026 06 23", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/akums-drugs-10039335-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-hold-4063320", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_mojoScore_4063320.png", "date": "2026-06-19 10:10:04", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 June 2026, providing investors with an up-to-date view of its performance and outlook." }, { "title": "Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 634.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-new-52-week-high-at-rs63495-4054191", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_priceRelatedfactors_4054191.png", "date": "2026-06-15 10:01:02", "description": "With a decisive break above Rs 634.95 on 15 Jun 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Gains 12.47%: 3 Key Factors Driving the Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-gains-1247-3-key-factors-driving-the-surge-4050687", "imagepath": "", "date": "2026-06-13 09:05:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 June:</strong> Stock opens week at Rs.546.65, down 1.31% amid Sensex decline</p>\n <p><strong>10 June:</strong> Intraday high surge of 7.55% to Rs.587.5</p>\n <p><strong>11 June:</strong> New 52-week high at Rs.606.2</p>\n <p><strong>12 June:</strong> New 52-week high extended to Rs.629, closing at Rs.622.95</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.553.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.622.95</div><div ..." }, { "title": "Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 629", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-new-52-week-high-at-rs629-4048632", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_priceRelatedfactors_4048632.png", "date": "2026-06-12 09:48:55", "description": "With a decisive surge to Rs 629 on 12 Jun 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally is underpinned by a confluence of bullish technical indicators and sustained gains over the past week, setting the stock apart in the Pharmaceuticals & Biotechnology sector." }, { "title": "Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 606.2", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-new-52-week-high-at-rs6062-4046225", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_priceRelatedfactors_4046225.png", "date": "2026-06-11 09:44:22", "description": "With a decisive surge to Rs 606.2 on 11 Jun 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This advance comes amid a three-day winning streak that has propelled the stock up by 10% over this short span, outpacing its sector by 1.25% today alone." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Surges 7.55% to Day's High of Rs 587.5 — Outperforms Sector by 6.4 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-intraday-high-with-755-surge-4044282", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_priceRelatedfactors_4044282.png", "date": "2026-06-10 14:31:26", "description": "The Sensex advanced 0.53% on 10 Jun 2026, yet Akums Drugs & Pharmaceuticals Ltd outpaced the broader market with a robust 7.55% gain, reaching an intraday high of Rs 587.5. This 6.4 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift." }, { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-hold-4037938", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_mojoScore_4037938.png", "date": "2026-06-08 10:10:04", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-hold-4037902", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_mojoScore_4037902.png", "date": "2026-06-07 10:10:05", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-shows-bullish-momentum-amid-technical-upgrades-4033057", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AkumsDrugsPharm_technicaldot_4033057.png", "date": "2026-06-03 08:07:09", "description": "Akums Drugs & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that suggest improving investor sentiment and potential upside in the near term. The company’s recent upgrade from a Sell to Hold rating, alongside positive signals from MACD, Bollinger Bands, and moving averages, marks a significant change in its technical outlook within the Pharmaceuticals & Biotechnology sector." } ], "total": 210, "sid": "10039335", "stock_news_url": "https://www.marketsmojo.com/news/akums-drugs-pharmaceuticals-10039335" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "19-Jun-2026", "details": "Newspaper Advertisements of the 22nd Annual General Meeting of the Company", "source": "BSE" }, { "caption": "Notice And Integrated Annual Report For The Financial Year 2025-26 To Those Members Who Have Not Registered Their E-Mail IDS", "datetime": "19-Jun-2026", "details": "Notice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail IDs", "source": "BSE" }, { "caption": "Reg. 34 (1) Annual Report.", "datetime": "18-Jun-2026", "details": "Integrated Annual Report for the FY 2025-26", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Akums Drugs & Pharmaceuticals Ltd has declared <strong>50%</strong> dividend, ex-date: 03 Jul 26", "dt": "2026-07-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

8 June: Stock opens week at Rs.546.65, down 1.31% amid Sensex decline

10 June: Intraday high surge of 7.55% to Rs.587.5

11 June: New 52-week high at Rs.606.2

12 June: New 52-week high extended to Rs.629, closing at Rs.622.95

Read full news article

Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 629

2026-06-12 09:48:55

With a decisive surge to Rs 629 on 12 Jun 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally is underpinned by a confluence of bullish technical indicators and sustained gains over the past week, setting the stock apart in the Pharmaceuticals & Biotechnology sector.

Read full news article

Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 606.2

2026-06-11 09:44:22

With a decisive surge to Rs 606.2 on 11 Jun 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This advance comes amid a three-day winning streak that has propelled the stock up by 10% over this short span, outpacing its sector by 1.25% today alone.

Read full news article

Akums Drugs & Pharmaceuticals Ltd Surges 7.55% to Day's High of Rs 587.5 — Outperforms Sector by 6.4 Percentage Points

2026-06-10 14:31:26

The Sensex advanced 0.53% on 10 Jun 2026, yet Akums Drugs & Pharmaceuticals Ltd outpaced the broader market with a robust 7.55% gain, reaching an intraday high of Rs 587.5. This 6.4 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Akums Drugs & Pharmaceuticals Ltd is Rated Hold

2026-06-08 10:10:04

Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Akums Drugs & Pharmaceuticals Ltd is Rated Hold

2026-06-07 10:10:05

Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Akums Drugs & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-06-03 08:07:09

Akums Drugs & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that suggest improving investor sentiment and potential upside in the near term. The company’s recent upgrade from a Sell to Hold rating, alongside positive signals from MACD, Bollinger Bands, and moving averages, marks a significant change in its technical outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article